| Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia RA Zittoun, F Mandelli, R Willemze, T De Witte, B Labar, L Resegotti, ... New England Journal of Medicine 332 (4), 217-223, 1995 | 1085 | 1995 |
| Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final … M Lübbert, S Suciu, L Baila, BH Rüter, U Platzbecker, A Giagounidis, ... Journal of clinical oncology 29 (15), 1987-1996, 2011 | 630 | 2011 |
| Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission … S Suciu, F Mandelli, T de Witte, R Zittoun, E Gallo, B Labar, G De Rosa, ... Blood 102 (4), 1232-1240, 2003 | 445 | 2003 |
| Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma H Ludwig, R Hajek, E Tóthová, J Drach, Z Adam, B Labar, M Egyed, ... Blood, The Journal of the American Society of Hematology 113 (15), 3435-3442, 2009 | 284 | 2009 |
| Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10 F Mandelli, M Vignetti, S Suciu, R Stasi, MC Petti, G Meloni, P Muus, ... Journal of clinical oncology 27 (32), 5397, 2009 | 240 | 2009 |
| Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS T de Witte, S Suciu, G Verhoef, B Labar, E Archimbaud, C Aul, D Selleslag, ... Blood, The Journal of the American Society of Hematology 98 (8), 2326-2331, 2001 | 213 | 2001 |
| Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome B Deschler, G Ihorst, U Platzbecker, U Germing, E März, M de Figuerido, ... haematologica 98 (2), 208, 2013 | 204 | 2013 |
| High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial R Willemze, S Suciu, GR Meloni, B Labar, JP Marie, CJM Halkes, P Muus, ... Journal of clinical oncology 32 (3), 219-228, 2014 | 184 | 2014 |
| Relationship between differing volumes of bone marrow aspirates and their cellular composition. D Batinić, M Marusić, Z Pavletić, V Bogdanić, B Uzarević, D Nemet, ... Bone marrow transplantation 6 (2), 103-107, 1990 | 127 | 1990 |
| A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia … R Willemze, S Suciu, E Archimbaud, P Muus, P Stryckmans, EA Louwagie, ... Leukemia (08876924) 11, 1997 | 120 | 1997 |
| Low dose decitabine versus best supportive care in elderly patients with intermediate or high risk MDS not eligible for intensive chemotherapy: final results of the randomized … P WijerMans, S Suciu, L Baila, U Platzbecker, A Giagounidis, D Selleslag, ... Blood 112 (11), 226, 2008 | 117 | 2008 |
| The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and … S KEATING, T DE WITTE, S Suciu, R WILLEMZE, M HAYAT, B LABAR, ... British journal of haematology 102 (5), 1344-1353, 1998 | 111 | 1998 |
| Prostaglandin E2 for prophylaxis of oral mucositis following BMT. B Labar, M Mrsić, Z Pavletić, V Bogdanić, D Nemet, I Aurer, I Radman, ... Bone marrow transplantation 11 (5), 379-382, 1993 | 102 | 1993 |
| Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III … M Lübbert, S Suciu, A Hagemeijer, B Rüter, U Platzbecker, A Giagounidis, ... Annals of hematology 95, 191-199, 2016 | 99 | 2016 |
| Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma H Ludwig, Z Adam, E Tóthová, R Hajek, B Labar, M Egyed, I Spicka, ... haematologica 95 (9), 1548, 2010 | 98 | 2010 |
| Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients< or= 50 years old in first complete remission: results of the EORTC … B Labar, S Suciu, R Zittoun, P Muus, JP Marie, G Fillet, M Peetermans, ... haematologica 89 (7), 809-817, 2004 | 95 | 2004 |
| Interna medicina B Vrhovac, I Francetić, B Jakšić, B Labar, B Vucelić Zagreb: Naklada Ljevak 719, 2003 | 80 | 2003 |
| FCγRIIIA and FCγRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma Z Mitroviç, I Aurer, I Radman, R Ajdukoviç, J Sertiç, B Labar Haematologica 92 (7), 998-999, 2007 | 79 | 2007 |
| The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia M Pfirrmann, RE Clark, W Prejzner, M Lauseker, M Baccarani, S Saussele, ... Leukemia 34 (8), 2138-2149, 2020 | 73 | 2020 |
| LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy A Vince, SŽ Lepej, B Baršić, D Dušek, Z Mitrović, R Serventi-Seiwerth, ... Journal of medical microbiology 57 (10), 1306-1307, 2008 | 71 | 2008 |
